TAMPA, Florida, March 1, 2010 /PRNewswire-FirstCall/ --
- Reference Tool Puts Real-Time, Evidence-Based Drug Information Onto Mobile Devices at the Point of Care
- Test Drive Clinical Pharmacology Mobile at HIMSS10
Gold Standard/Elsevier (http://www.goldstandard.com), a leading provider of drug decision support announced today the availability of Clinical Pharmacology Mobile, a mobile device-optimized web site offering users access to the features and functions of Clinical Pharmacology, an award-winning electronic drug information and medication management reference. Experience Clinical Pharmacology Mobile at the HIMSS (Healthcare Information Management Systems Society) annual meeting, March 1-4, 2010, in Atlanta (Elsevier's Booth #6503/6509).
"Clinical Pharmacology Mobile provides healthcare professionals and students with reliable, need-to-know drug information when and where they need it. We've built a mobile version looking to the future and to our customers' emerging needs," said Kathy Vieson, PharmD, BCOP, Vice President and Director of Clinical Drug References for Gold Standard/Elsevier. "The release of Clinical Pharmacology Mobile reflects Gold Standard's commitment to provide quality drug information and accurate answers to point-of-care questions with enhanced speed, ease and convenience."
Focused on supporting routine medication information needs, Clinical Pharmacology Mobile allows users to search by trade or generic drug name, indication, contraindication/precaution or adverse reaction, and to browse by monograph or classification. Clinicians can access drug monographs, multi-drug interaction reports, MedCounselor consumer medication information, drug product information, drug images and clinical calculators. In addition, users can purchase supplemental modules such as Drug IDentifier/NDC Search, IV Compatibility information and reports via Trissel's 2 Database, Global Drug Name Directory, FormChecker hospital formulary management and OnFormulary health plan formularies.
The Clinical Pharmacology Mobile web site is supported on devices that use standard browsers, such as the iPhone/iPod Touch, BlackBerry devices, T Mobile G1 and Nokia N85, and runs on the Apple, RIM, Android, Symbian, and Windows Mobile 6 operating systems.
"With nothing to download, no synching required and continuous updating, Clinical Pharmacology Mobile provides users with the most timely, accurate and reliable drug information available," says Vieson. "By adding Clinical Pharmacology Mobile to our drug reference suite, our goal is to ensure our customers have the content they need at every access point, be that online, in their workflow systems and now on their mobile devices."
The number of cell phone subscriptions across the globe will hit 5 billion sometime in 2010, precipitated in part by the demand for mobile healthcare services, according to the International Telecommunication Union. McKinsey & Company projects that the global mobile health opportunity could be worth more than $60 billion, while Mobile Health Initiative founder Peter Waegemann predicts a mobile health revolution where publishers move scientific knowledge "from books to apps."
About Gold Standard
Based in Tampa, FL, Gold Standard/Elsevier uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Gold Standard/Elsevier solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Gold Standard/Elsevier, visit http://www.goldstandard.com.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Tom Reller VP, Global Corporate Relations, Elsevier +1-215-239-3508 T.Reller@elsevier.com
SOURCE ElsevierBack to top
Copyright©2010 PR Newswire.
All rights reserved